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346 amino acids. 
Function 
XRCC3 is required for efficient repair of double strand 
breaks via homologous recombinational repair (link), 
for correct chromosomal segregation and for repair of 
DNA cross links. Inactivation of XRCC3 in CHO cells 
results in increased radiation and cisplatin sensitivity. 
In human cells, XRCC3 forms a complex with Rad51C 
which is recruited early to DNA damage. Inactivation 
of XRCC3 in human cells leads to a two-fold 
sensitivity to DNA cross-linking agents, impaired 
Rad51 focus formation, elevated chromosome 
aberrations and five to seven-fold increased 
endoreduplication. 
Homology 




No human disease has been linked to 
inactivation of XRCC3. However, 
polymorphisms in XRCC3 may be associated 
with increased cancer risk (see below). 
Note: Genetic Epidemiology:  
The most frequent polymorphism in XRCC3 is XRCC3 
C18067T which results in a Thr to Met amino acid 
substitution at codon 241. Carriers of the variant T-
allele of XRCC3 T241M have higher DNA adduct 
levels in lymphocyte DNA compared to homozygous 
C-allele carriers, indicating that the polymorphism is 
associated with lowered DNA repair capacity. The 
variant allele of XRCC3 T241M polymorphism has 
been associated with increased risk of squamous cell 
carcinoma of the head and neck in one study while 
another study found no association. No association has 
previously been found with colon cancer, non-
melanoma skin cancer, prostate cancer, gastric cancer, 
ovarian cancer. Conflicting results have been published 
on the association with breast cancer, bladder cancer, 
malignant melanoma and lung cancer. 
Two frequent SNP are upstream of XRCC3 T241M 
have also been studied, namely XRCC3 A4541G and 
XRCC3 A17897G. Neither polymorphism gives rise to 
amino acid changes. The variant allele of A17897G has 
been associated with decreased risk of breast cancer 
and ovarian cancer. The same tendency, but no 
significant associations was found for lung cancer. 
XRCC3 A4541G was not associated to risk of breast 
cancer or lung cancer. However, homozygote carriers 
of the variant allele had lower risk of serous epithelial 
ovarian cancer. 
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